Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Fructose 1,6-bisphosphate
2. Fructose 1,6-diphosphate
3. Fructose-1,6-diphosphate
4. Fructose-1,6-diphosphate Magnesium Salt
5. Fructose-1,6-diphosphate, (alpha-d)-isomer
6. Fructose-1,6-diphosphate, (beta-d)-isomer
7. Fructose-1,6-diphosphate, (l)-isomer
8. Fructose-1,6-diphosphate, 2-(18)o-labeled
9. Fructose-1,6-diphosphate, Barium (1:2) Salt
10. Fructose-1,6-diphosphate, Calcium (1:2) Salt
11. Fructose-1,6-diphosphate, Calcium Salt
12. Fructose-1,6-diphosphate, Disodium Salt
13. Fructose-1,6-diphosphate, Monosodium Salt
14. Fructose-1,6-diphosphate, Sodium Salt, Monohydrate
15. Fructose-1,6-diphosphate, Tetrapotassium Salt
16. Fructose-1,6-diphosphate, Tetrasodium Salt
17. Fructose-1,6-diphosphate, Trisodium Salt
18. Sr-fdp
19. Strontium Fructose 1,6-diphosphate
20. Strontium Fructose-1,6-diphosphate
1. Beta-d-fructose 1,6-bisphosphate
2. Fructose-1,6-diphosphate
3. Beta-d-fructofuranose 1,6-bisphosphate
4. Beta-fructose-1,6-diphosphate
5. 34693-15-7
6. Fbp
7. Fructose 1,6-diphosphate
8. Chebi:28013
9. Fructose 1,6-bisphosphate
10. Fructose-1,6-bisphosphate
11. D-fructose-1,6-diphosphate
12. Esafosfan
13. Beta-d-fructofuranose 1,6-bis(dihydrogen Phosphate)
14. Diphosphofructose
15. [(2r,3s,4s,5r)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl Dihydrogen Phosphate
16. D-fructose 1,6-biphosphate
17. 488-69-7
18. Ncgc00166321-01
19. Fructose Bisphosphate
20. Fructose 1,6-bis
21. Esafosfina
22. Beta Fructose 1,6-diphosphate
23. 1bo5
24. Bmse000011
25. Wch874xlb1
26. D-fructose 1,6-diphosphate
27. D-fructose-1,6-bisphosphate
28. Chembl97893
29. Schembl168244
30. .beta.-d-fructofuranose, 1,6-bis(dihydrogen Phosphate)
31. Dtxsid0048347
32. Beta-d-fructose-1,6-diphosphate
33. .beta.-d-fosfructofuranose
34. Zinc4096694
35. Einecs 251-977-7
36. Db04551
37. C05378
38. .beta.-d-fructofuranose 1,6-diphosphate
39. Q414945
40. Beta-d-fructofuranose, 1,6-bis(dihydrogen Phosphate)
41. Beta-d-fructofuranose 1,6-bisphosphate (rssr Closed Ring)
42. 16eb39bb-b854-429f-972f-0d8401178a36
43. Wurcs=2.0/1,1,0/[ha122h-2b_2-5_1*opo/3o/3=o_6*opo/3o/3=o]/1/
Molecular Weight | 340.12 g/mol |
---|---|
Molecular Formula | C6H14O12P2 |
XLogP3 | -5.6 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 6 |
Exact Mass | 339.99604987 g/mol |
Monoisotopic Mass | 339.99604987 g/mol |
Topological Polar Surface Area | 203 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 428 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
Immunologic Factors
Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01E - Other cardiac preparations
C01EB - Other cardiac preparations
C01EB07 - Fructose 1,6-diphosphate
Global Sales Information
Market Place
ABOUT THIS PAGE
A Fructose 1,6-Bisphosphate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fructose 1,6-Bisphosphate Sodium, including repackagers and relabelers. The FDA regulates Fructose 1,6-Bisphosphate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fructose 1,6-Bisphosphate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fructose 1,6-Bisphosphate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fructose 1,6-Bisphosphate Sodium supplier is an individual or a company that provides Fructose 1,6-Bisphosphate Sodium active pharmaceutical ingredient (API) or Fructose 1,6-Bisphosphate Sodium finished formulations upon request. The Fructose 1,6-Bisphosphate Sodium suppliers may include Fructose 1,6-Bisphosphate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Fructose 1,6-Bisphosphate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fructose 1,6-Bisphosphate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Fructose 1,6-Bisphosphate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Fructose 1,6-Bisphosphate Sodium DMFs exist exist since differing nations have different regulations, such as Fructose 1,6-Bisphosphate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fructose 1,6-Bisphosphate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Fructose 1,6-Bisphosphate Sodium USDMF includes data on Fructose 1,6-Bisphosphate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fructose 1,6-Bisphosphate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fructose 1,6-Bisphosphate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fructose 1,6-Bisphosphate Sodium Drug Master File in Japan (Fructose 1,6-Bisphosphate Sodium JDMF) empowers Fructose 1,6-Bisphosphate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fructose 1,6-Bisphosphate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Fructose 1,6-Bisphosphate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fructose 1,6-Bisphosphate Sodium suppliers with JDMF on PharmaCompass.
Fructose 1,6-Bisphosphate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fructose 1,6-Bisphosphate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fructose 1,6-Bisphosphate Sodium GMP manufacturer or Fructose 1,6-Bisphosphate Sodium GMP API supplier for your needs.
A Fructose 1,6-Bisphosphate Sodium CoA (Certificate of Analysis) is a formal document that attests to Fructose 1,6-Bisphosphate Sodium's compliance with Fructose 1,6-Bisphosphate Sodium specifications and serves as a tool for batch-level quality control.
Fructose 1,6-Bisphosphate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Fructose 1,6-Bisphosphate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fructose 1,6-Bisphosphate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Fructose 1,6-Bisphosphate Sodium EP), Fructose 1,6-Bisphosphate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fructose 1,6-Bisphosphate Sodium USP).
LOOKING FOR A SUPPLIER?